Glenn A. Eisenberg - 21 Feb 2024 Form 4 Insider Report for LABORATORY CORP OF AMERICA HOLDINGS (LH)

Role
Chief Financial Officer, EVP
Signature
/s/ Sandra D. van der Vaart, Attorney-in-Fact for Glenn A. Eisenberg
Issuer symbol
LH
Transactions as of
21 Feb 2024
Net transactions value
-$5,152,210
Form type
4
Filing time
22 Feb 2024, 15:05:42 UTC
Previous filing
13 Feb 2024
Next filing
29 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LH Common Stock Options Exercise $2,299,656 +14,054 +32% $163.63 58,099 21 Feb 2024 Direct
transaction LH Common Stock Sale $3,958,214 -18,379 -32% $215.37 39,720 21 Feb 2024 Direct F1
transaction LH Common Stock Sale $1,705,349 -7,907 -20% $215.68 31,813 21 Feb 2024 Direct F2
transaction LH Common Stock Sale $1,449,774 -6,665 -21% $217.52 25,148 21 Feb 2024 Direct F3
transaction LH Common Stock Sale $338,529 -1,553 -6.2% $217.98 23,595 21 Feb 2024 Direct F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LH Non-qualified Stock Options Options Exercise $0 -14,054 -100% $0.000000* 0 21 Feb 2024 Common Stock 14,054 $163.63 Direct F5, F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price of $215.3661 per share represents a weighted average of sales prices ranging from $214.80 to $215.79 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
F2 The price of $215.6759 per share represents a weighted average of sales prices ranging from $215.80 to $216.66 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
F3 The price of $217.5205 per share represents a weighted average of sales prices ranging from $216.87 to $217.86 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
F4 The price of $217.9842 per share represents a weighted average of sales prices ranging from $217.89 to $218.075 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
F5 Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan.
F6 Represents amounts automatically adjusted based on the final adjustment ratio applied to equity awards in connection with the spin-off of Fortrea Holdings Inc. ("Fortrea") by Laboratory Corporation of America Holdings ("Labcorp"), calculated pursuant to the terms of the Employee Matters Agreement by and between Labcorp and Fortrea.
F7 The option vested in three equal annual installments beginning on the date reflected in this column.